Medical School, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Diabetologia. 2015 May;58(5):1036-44. doi: 10.1007/s00125-015-3521-z. Epub 2015 Feb 28.
AIMS/HYPOTHESIS: ANGPTL8 is a circulatory hormone secreted from liver and adipose tissue that promotes pancreatic beta cell proliferation and interferes with triacylglycerol metabolism in mice. The clinical significance of its effects on inducing beta cell proliferation is limited because it causes severe hypertriacylglycerolaemia.
We employed ultrasound-targeted microbubble destruction (UTMD) to deliver human ANGPTL8 gene plasmids to the pancreas, liver and skeletal muscle of normal adult rats.
Human ANGPTL8 was consistently detected in the circulation 1 month after UTMD. ANGPTL8 gene delivery promoted the proliferation of adult and aged beta cells, expanded the beta cell mass, improved glucose tolerance and increased the fasting blood insulin level after UTMD treatment without causing severe hypertriacylglycerolaemia. ANGPTL8 gene therapy significantly alleviated but did not totally reverse STZ-induced diabetes in a rat model.
CONCLUSIONS/INTERPRETATION: ANGPTL8 induced adult and aged beta cell regeneration in a rat model.
目的/假设:ANGPTL8 是一种从肝脏和脂肪组织分泌的循环激素,它能促进胰腺 β 细胞增殖,并干扰小鼠的三酰甘油代谢。由于其导致严重的高三酰甘油血症,其诱导 β 细胞增殖的临床意义有限。
我们采用超声靶向微泡破坏(UTMD)将人 ANGPTL8 基因质粒递送至正常成年大鼠的胰腺、肝脏和骨骼肌。
UTMD 后 1 个月,人 ANGPTL8 持续在循环中被检测到。ANGPTL8 基因传递促进了成年和老年 β 细胞的增殖,扩大了 β 细胞群,改善了葡萄糖耐量,并在 UTMD 治疗后增加了空腹胰岛素水平,而没有导致严重的高三酰甘油血症。ANGPTL8 基因治疗显著缓解了但并未完全逆转 STZ 诱导的大鼠糖尿病。
结论/解释:ANGPTL8 在大鼠模型中诱导了成年和老年 β 细胞的再生。